Back to search
FDAFDA · Food and drugs·Recall number D-0147-2021

Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205

Published December 23, 2020 · Recall initiated: November 20, 2020

Summary

FDA records drug Class III recall D-0147-2021, published December 23, 2020 and initiated November 20, 2020. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: 4,843 syringes; Lot: Lot #: 1220021578, Exp 12/2/2020; 1220021732, Exp 12/9/2020; 1220022385, Exp 12/29/2020; 1220022582, Exp 1/6/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotency: Out-of-specification stability test result for low potency was obtained.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals
Distributor
Product was distributed to three hospitals in MO & LA.
Lot
Lot #: 1220021578, Exp 12/2/2020; 1220021732, Exp 12/9/2020; 1220022385, Exp 12/29/2020; 1220022582, Exp 1/6/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205 recalled?

Yes. FDA published recall D-0147-2021 on December 23, 2020. Reported hazard: Subpotency: Out-of-specification stability test result for low potency was obtained.

What should I do if I have this product?

Voluntary: Firm initiated · Letter